Weve seen many patients reverse their tendencies for high blood pressure, elevated blood sugars, and uncontrollable appetites
Patients who received the drug experienced a 40 percent decline in their desire for opioids compared with those who got a placebo
GLP-1 receptor agonists, which include semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), mimic a gut hormone released after eating
GLP-1 treatment can make appetite management easier for some people, but it does not automatically protect muscle, improve diet quality, manage side effects, or create a maintenance plan
Asia-Pacific : Rapidly Growing Market Segment The Asia-Pacific region is emerging as a significant player in the GLP-1 drug market, accounting for about 15% of the global share
If there is no obvious cause, e.g